Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes.
Ramos EL, Dayan CM, Chatenoud L, Sumnik Z, Simmons KM, Szypowska A, Gitelman SE, Knecht LA, Niemoeller E, Tian W, Herold KC; PROTECT Study Investigators. Ramos EL, et al. N Engl J Med. 2023 Dec 7;389(23):2151-2161. doi: 10.1056/NEJMoa2308743. Epub 2023 Oct 18. N Engl J Med. 2023. PMID: 37861217 Clinical Trial.
Twelve-month psychosocial outcomes of continuous glucose monitoring with behavioural support in parents of young children with type 1 diabetes.
Commissariat PV, DiMeglio LA, Kanapka LG, Laffel LM, Miller KM, Anderson BJ, Hilliard ME; Strategies to Enhance New CGM Use in Early Childhood (SENCE) Study Group. Commissariat PV, et al. Diabet Med. 2023 Aug;40(8):e15120. doi: 10.1111/dme.15120. Epub 2023 May 2. Diabet Med. 2023. PMID: 37083018 Free PMC article. Clinical Trial.
Candidate biomarkers as predictors of future kidney disease and cardiovascular dysfunction in adolescents with type 2 diabetes.
Bacha F, El Ghormli L, Braffett BH, Shah AS, Marcovina SM, Levitt Katz LE, Willi SM, Caprio S, Dhaliwal R, Gidding SS; for theTODAYStudy Group. Bacha F, et al. Among authors: willi sm. Diabetes Res Clin Pract. 2023 May;199:110671. doi: 10.1016/j.diabres.2023.110671. Epub 2023 Apr 15. Diabetes Res Clin Pract. 2023. PMID: 37068551 Free PMC article.
Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.
Wadwa RP, Reed ZW, Buckingham BA, DeBoer MD, Ekhlaspour L, Forlenza GP, Schoelwer M, Lum J, Kollman C, Beck RW, Breton MD; PEDAP Trial Study Group. Wadwa RP, et al. N Engl J Med. 2023 Mar 16;388(11):991-1001. doi: 10.1056/NEJMoa2210834. N Engl J Med. 2023. PMID: 36920756 Free PMC article. Clinical Trial.
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial.
Laffel LM, Danne T, Klingensmith GJ, Tamborlane WV, Willi S, Zeitler P, Neubacher D, Marquard J; DINAMO Study Group. Laffel LM, et al. Among authors: willi s. Lancet Diabetes Endocrinol. 2023 Mar;11(3):169-181. doi: 10.1016/S2213-8587(22)00387-4. Epub 2023 Feb 1. Lancet Diabetes Endocrinol. 2023. PMID: 36738751 Free PMC article. Clinical Trial.
194 results